Mancini Marianna's Form 4 filing
Viking Therapeutics, Inc. (VKTX) · filed Mar 30, 2023
- Accession no.
- 0001209191-23-021743
- Filed
- Mar 30, 2023
- Trade date
- Mar 28-29, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 11 non-derivative transactions and 9 derivative transactions. Open-market sales total $3.61M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mancini MariannaCIK 0001838112 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 28, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +15,000 | $2.15 | +$32,250 | 332,273 | Direct | |
| Mar 28, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +4,873 | $1.88 | +$9,161.24 | 337,146 | Direct | |
| Mar 28, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +15,000 | $1.26 | +$18,900 | 352,146 | Direct | |
| Mar 28, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +53,054 | $1.23 | +$65,256.42 | 405,200 | Direct | |
| Mar 28, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +15,000 | $1.08 | +$16,200 | 420,200 | Direct | |
| Mar 28, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +10,000 | $1.04 | +$10,400 | 430,200 | Direct | |
| Mar 28, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +24,500 | $4.65 | +$113,925 | 454,700 | Direct | |
| Mar 28, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +30,000 | $4.37 | +$131,100 | 484,700 | Direct | |
| Mar 28, 2023 | Common Stock, par value $0.00001 per share | SSaleDisposed | −196,563 | $15.00 | −$2,948,445 | 288,137 | Direct | |
| Mar 29, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +15,000 | $9.13 | +$136,950 | 303,137 | Direct | |
| Mar 29, 2023 | Common Stock, par value $0.00001 per share | SSaleDisposed | −41,242 | $16.00 | −$659,872 | 261,895 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 28, 2023 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 0 | Direct | |
| Mar 28, 2023 | Common Stock | MOption exerciseDisposed | −4,873 | $0.00 | $0 | 0 | Direct | |
| Mar 28, 2023 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 0 | Direct | |
| Mar 28, 2023 | Common Stock | MOption exerciseDisposed | −53,054 | $0.00 | $0 | 0 | Direct | |
| Mar 28, 2023 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 0 | Direct | |
| Mar 28, 2023 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 0 | Direct | |
| Mar 28, 2023 | Common Stock | MOption exerciseDisposed | −24,500 | $0.00 | $0 | 0 | Direct | |
| Mar 28, 2023 | Common Stock | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 0 | Direct | |
| Mar 29, 2023 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.